Physician profile
Michael J Coffey
NPI 1215138607
$905.83
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $128 · 2021: $126 · 2022: $188 · 2023: $87.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $262.25 | 2019-2022 | |
| Arthrex, INC. | $153.37 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $123.34 | 2019 | |
| Pacira Therapeutics, INC. | $116.75 | 2019-2021 | |
| Conetic Solutions, INC. | $99.13 | 2021-2023 | |
| Depuy Synthes Sales INC. | $81.41 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $30.09 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $14.54 | 2019 | |
| Smith+Nephew, INC. | $13.92 | 2021 | |
| Pfizer INC. | $11.03 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Coffey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.